BMP6
protein-codingbone morphogenetic protein 6, the group of Bone morphogenetic proteins
Gene summary
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates a wide range of biological processes including iron homeostasis, fat and bone development, and ovulation. Differential expression of this gene may be associated with progression of breast and prostate cancer. Mutations in this gene may be associated with iron overload in human patients. [provided by RefSeq, Jul 2016]
- VGR
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~155.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0859316
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859316
Submitter: ClinGen
The *BMP6* gene was first reported in relation to susceptibility to iron overload in 2006 (Babitt JL et al., PMID: 19252488), showing that BMP6 upregulates hepatocyte hepcidin expression—a process enhanced by hemojuvelin and blunted in* Hfe2*−/− hepatocytes. Per the criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism and inheritance pattern.Six missense variants, with at least six probands reported in association with iron overload across six publications (PMID: 26582087, PMID: 28335084, PMID: 29695288, PMID: 27590690, PMID: 34037557, PMID: 38719717), were evaluated but not included due to high allele frequency in healthy populations (gnomAD v4.1).One missense variant, c.1180G>A (p.Val394Met), with additional in vitro assay data showing a three-fold reduction in hepcidin induction by the mutant compared to wild-type BMP6, was included in this curation (PMID: 34037557). The mechanism of pathogenicity appears to be loss of function.This gene-disease relationship is also supported by animal models showing accumulation of iron in the liver, the acinar cells of the exocrine pancreas, the heart, and the renal convoluted tubules (PMID: 19252488; PMID: 19252486), as well as expression studies showing *Bmp6 *expression induced by dietary iron content (PMID: 18539898). In summary, there is limited evidence supporting the relationship between *BMP6* and susceptibility to iron overload. This classification was approved by the ClinGen IEM GCEP at the meeting on May 9, 2025 (SOP Version 11).
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: The condition may involve increased risk of liver dysfunction, and awareness may allow preventative measures such as avoidance of other risk factors for hepatic dysfunction
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BMP6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001718.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 4 | 16 | ||
| missense | 1 | 95 | 8 | 2 | 106 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 1 | 99 | 19 | 6 | 125 |
Highest pathogenic variant AF is 0.000019206682
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001709.1 | 7 | MANE Select | |
| Ensembl | ENSP00000283147.6 | 7 | MANE Select | |
| Ensembl | ENSP00000616142.1 | 7 | Standard | |
| Ensembl | ENSP00000616142.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Ovarian steroidogenesis - Homo sapiens (human)
- TGF-Core
- Vitamin D Receptor Pathway
Biological Process
- negative regulation of transcription by RNA polymerase II
- skeletal system development
- osteoblast differentiation
- eye development
- kidney development
Molecular Function
- cytokine activity
- transforming growth factor beta receptor binding
- growth factor activity
- protein heterodimerization activity
- BMP receptor binding
Cellular Component
- extracellular space
- cytoplasm
- vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000283147
- Coding exons
- 7
- Length
- 154626
- Individuals with no LoFs
- 125744
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125748
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.03 | 315 | 268 | 1.18 | 0.0000153 | 3306 |
| Missense (PolyPhen) | 130 | 128.12 | 1.0147 | 1444 | ||
| Synonymous | -0.660 | 120 | 111 | 1.08 | 0.00000657 | 1020 |
| Loss of Function | 3.59 | 4 | 22.3 | 0.180 | 0.00000122 | 239 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Induces cartilage and bone formation.;
Recessive Scores
- pRec
- 0.373
Intolerance Scores
- LoFtool
- 0.0702
- RVIS EVS
- -0.34
- RVIS percentile EVS
- 30.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.936
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |